Skip to content

Clinical trials

Phase 1/2 Cholangiocarcinoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 1/2 Country / region: South Korea Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20182
20191
20202
20211
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
Bold Therapeutics, Inc.1
DualityBio Inc.1
Elevar Therapeutics1
Forma Therapeutics, Inc.1
Medivir1
NGM Biopharmaceuticals, Inc1
SMT bio Co., Ltd.1
Senhwa Biosciences, Inc.1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma11
Biliary Tract Neoplasms4
Stomach Neoplasms4
Bile Duct Neoplasms3
Breast Neoplasms3
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Glioblastoma2
Squamous Cell Carcinoma of Head and Neck2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.